Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SHE:300204)

SHE:300204 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 22, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,061	3,540	4,854	6,419	8,242	4,241
Market Cap Growth	6.07%	-27.07%	-24.38%	-22.12%	94.35%	-18.80%
Enterprise Value	6,981	3,498	4,711	6,113	7,806	3,550
Last Close Price	14.78	7.41	10.16	13.60	17.55	9.03
Forward PE	-	78.50	78.50	78.50	78.50	78.50
PS Ratio	24.10	10.90	13.33	11.69	14.11	9.97
PB Ratio	7.49	3.86	4.76	4.74	5.32	2.67
P/TBV Ratio	7.85	4.05	5.03	5.12	5.70	2.86
EV/Sales Ratio	23.82	10.77	12.94	11.14	13.36	8.35
EV/FCF Ratio	-84.48	-	-	-	-	-
Debt / Equity Ratio	0.02	0.03	0.04	0.02	0.01	0.03
Asset Turnover	0.24	0.26	0.24	0.31	0.32	0.23
Inventory Turnover	2.53	2.89	3.75	4.64	3.69	1.74
Quick Ratio	0.96	0.61	0.71	1.96	3.18	4.09
Current Ratio	1.59	1.15	1.15	2.28	3.50	4.34
Return on Equity (ROE)	-15.05%	-15.25%	-33.60%	-13.56%	-8.76%	-8.25%
Return on Assets (ROA)	-1.76%	-1.72%	-15.56%	-8.36%	-8.13%	-6.38%
Return on Capital (ROIC)	-2.16%	-2.13%	-19.11%	-9.94%	-9.37%	-7.25%
Earnings Yield	-2.03%	-4.09%	-8.22%	-3.07%	-1.67%	-3.14%
FCF Yield	-1.17%	-2.46%	-5.37%	-3.62%	-2.65%	-3.85%
Buyback Yield / Dilution	-	-1.67%	1.17%	-1.42%	0.27%	-4.41%
Total Shareholder Return	-	-1.67%	1.17%	-1.42%	0.27%	-4.41%

Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.